As such, our study is the first to show that the metoclopramide test is helpful to distinguish hPRL secondary to microprolactinoma as compared to other causes of hPRL in PCOS women, and therefore could be an interesting tool for discussing the relevance of a pituitary MRI. Here, PRLR is linked to polycystic ovary syndrome.